| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |